tiprankstipranks
Advertisement
Advertisement

UCBJY Stock Latest News

Cullinan jumps after UCB acquires Candid Therapeutics
The FlyCullinan jumps after UCB acquires Candid Therapeutics
1d ago
CGEM
UCB to acquire Neurona Therapeutics
PremiumThe Fly
UCB to acquire Neurona Therapeutics
18d ago
UCB downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
UCB downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
UCB S.A. Earnings Call Highlights BIMZELX-Led Surge
PremiumCompany Announcements
UCB S.A. Earnings Call Highlights BIMZELX-Led Surge
2M ago
UCB initiated with an Outperform at Wolfe Research
PremiumThe Fly
UCB initiated with an Outperform at Wolfe Research
2M ago
UCB price target raised to EUR 304 from EUR 255 at Goldman Sachs
PremiumThe FlyUCB price target raised to EUR 304 from EUR 255 at Goldman Sachs
3M ago
UCB price target raised to EUR 310 from EUR 270 at Barclays
Premium
The Fly
UCB price target raised to EUR 310 from EUR 270 at Barclays
4M ago
UCB price target raised to EUR 295 from EUR 285 at Deutsche Bank
Premium
The Fly
UCB price target raised to EUR 295 from EUR 285 at Deutsche Bank
5M ago
UCB price target raised to EUR 300 from EUR 230 at JPMorgan
PremiumThe Fly
UCB price target raised to EUR 300 from EUR 230 at JPMorgan
5M ago
UCB removed from European Conviction List at Goldman Sachs
PremiumThe Fly
UCB removed from European Conviction List at Goldman Sachs
6M ago
UCB assumed with an Underperform at Jefferies
PremiumThe Fly
UCB assumed with an Underperform at Jefferies
6M ago
UCB announces new three-year data from Phase 3 trials on BIMZELX
PremiumThe Fly
UCB announces new three-year data from Phase 3 trials on BIMZELX
6M ago
UCB price target raised to EUR 290 from EUR 220 at Berenberg
PremiumThe FlyUCB price target raised to EUR 290 from EUR 220 at Berenberg
7M ago
UCB price target raised to EUR 285 from EUR 250 at Deutsche Bank
Premium
The Fly
UCB price target raised to EUR 285 from EUR 250 at Deutsche Bank
7M ago
UCB price target raised to EUR 240 from EUR 220 at Morgan Stanley
Premium
The Fly
UCB price target raised to EUR 240 from EUR 220 at Morgan Stanley
8M ago
UCB added to European Conviction List at Goldman Sachs
PremiumThe Fly
UCB added to European Conviction List at Goldman Sachs
8M ago
UCB S.A. Reports Strong Growth and Positive Outlook in 2025 Earnings Call
PremiumCompany Announcements
UCB S.A. Reports Strong Growth and Positive Outlook in 2025 Earnings Call
9M ago
UCB S.A. Reports Strong Growth and Positive Outlook
PremiumCompany Announcements
UCB S.A. Reports Strong Growth and Positive Outlook
9M ago
UCB initiated with a Buy at Goldman Sachs
PremiumThe Fly
UCB initiated with a Buy at Goldman Sachs
10M ago
UCB SA’s Growth Potential: Buy Rating on Bimzelx’s Transformative Impact
PremiumRatingsUCB SA’s Growth Potential: Buy Rating on Bimzelx’s Transformative Impact
10M ago
UCB reports positive results from Phase 3 study of fenfluramine in CDKL5
Premium
The Fly
UCB reports positive results from Phase 3 study of fenfluramine in CDKL5
10M ago
UCB upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
UCB upgraded to Overweight from Equal Weight at Morgan Stanley
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >